Back to Screener

Healthcare

ImmunityBio, Inc.(IBRX)

Live Price

Offline

$8.71

+11.81% today

Window Change

-2.13%

Window

May 29, 2026 โ†’ Jun 18, 2026

Market Cap
$7.30B
Revenue Growth
+668.3%
EPS Growth
+35.6%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars ยท May 29, 2026 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

ImmunityBio, Inc. (IBRX) is a Healthcare stock with a market cap of $7.30B and listed on NASDAQ. The stock last traded around $8.71 and down 2.1% across the available one-year price window (May 29, 2026 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +668.3%, EPS growth of +35.6%, a dividend yield of 0.0%. What stands out right now is revenue +668.3%, EPS +35.6%, free cash flow +22.4% with operating margin -226.0% and ROIC -56.9%. Valuation already assumes a fairly strong business story at price/sales 64.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines IBRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IBRX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

IBRX trails SPY

IBRX is 0.84 pts behind over the shared 1Y window.

IBRX had 1.51 pts deeper max drawdown than SPY.

IBRX beat SPY in 0 of 1 calendar years shown and trailed in 1.

IBRX

-2.13%

Normalized return

SPY

-1.29%

S&P 500

Excess Return

-0.84 pts

Relative to SPY

IBRX Max Drawdown

-10.64%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

IBRXSPY

Calendar-Year Returns

Uses the longest available daily history for IBRX and SPY.

YearIBRXSPYExcessLeader
2026-2.13%+6.71%-8.83 ptsSPY
2025โ€”+11.19%----

Earnings Reports

๐Ÿ“… Last reportedMay 11, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Feb 23, 26
โœ“
-0.06
Est -0.08
+25.0%
38.3M
Est 38.4M
-0.2%
Feb 23
โ€”
Nov 4, 25
โœ“
-0.07
Est -0.10
+30.0%
32.1M
Est 37.8M
-15.1%
Nov 4
โ€”
Aug 5, 25
โ€”
-0.10
Est -0.10
0.0%
26.4M
Est 31.9M
-17.1%
Aug 5
โ€”
May 12, 25
โœ—
-0.15
Est -0.12
-25.0%
16.5M
Est 16.6M
-0.5%
May 12
โ€”
Mar 3, 25
โœ“
-0.15
Est -0.26
+42.3%
7.6M
Est 9.6M
-21.5%
Mar 3
โ€”
Nov 12, 24
โœ“
-0.14
Est -0.18
+22.2%
6.1M
Est 9.1M
-32.7%
Nov 12
โ€”
Aug 12, 24
โœ—
-0.20
Est -0.17
-17.6%
1.0M
Est 2.5M
-58.5%
Aug 12
โ€”
May 9, 24
โœ—
-0.20
Est -0.16
-25.0%
40.0K
Est 20.0K
+100.0%
May 9
โ€”
Mar 19, 24
โœ—
-0.19
Est -0.18
-5.6%
139.0K
Est 20.0K
+595.0%
Mar 19
โ€”
Nov 8, 23
โœ“
-0.19
Est -0.27
+29.6%
82.0K
Est 20.0K
+310.0%
Nov 8
โ€”
Aug 8, 23
โœ—
-0.28
Est -0.26
-7.7%
41.0K
Est 360.0K
-88.6%
Aug 8
โ€”
May 11, 23
โ€”
-0.27
Est -0.27
0.0%
360.0K
Est 360.0K
0.0%
May 11
โ€”
Mar 1, 23
โœ—
-0.27
Est -0.22
-22.7%
73.0K
Est 25.0K
+192.0%
Mar 1
โ€”
Nov 9, 22
โœ—
-0.28
Est -0.23
-21.7%
118.0K
Est 118.0K
0.0%
Nov 9
โ€”
Aug 8, 22
โ€”
-0.24
Est -0.24
0.0%
35.0K
Est 25.0K
+40.0%
Aug 8
โ€”
May 10, 22
โœ—
-0.26
Est -0.22
-18.2%
14.0K
Est 25.0K
-44.0%
May 10
โ€”
Mar 2, 22
โœ—
-0.23
Est -0.21
-9.5%
390.0K
Est 25.0K
+1460.0%
Mar 2
โ€”
Nov 12, 21
โœ—
-0.22
Est -0.20
-10.0%
66.0K
Est 20.0K
+230.0%
Nov 12
โ€”
Aug 12, 21
โœ—
-0.23
Est -0.12
-91.7%
339.0K
Est 236.0K
+43.7%
Aug 12
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar